AssayIndex
Reports by quarter

Reports submitted in 2025-Q3 · page 8

Kestrel Bioanalytical began contributing; gradient-length normalisation introduced. Median purity for the quarter is 99.03 % area, n=816. Read the 2025-Q3 state-of-the-index report →

816 records21 pagesmedian on this page 99.06 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-020413LiraglutideMKMMKM-2508-P4928Janoshik2025-Q397.877.04—Buyer-sourced1FAIL
AX-2025-0201065-Amino-1MQSWBSWB-2507-E8786Janoshik2025-Q399.346.38—Buyer-sourced1FAIL
AX-2025-019870SemaglutideHJHJ-2507-E6156Medutest2025-Q399.835.35104.3Buyer-sourced0PASS
AX-2025-019773RetatrutideHomopeptideHOMO-2508-U3892PeptideMeter2025-Q398.716.82—Buyer-sourced0PASS
AX-2025-019634BPC-157TFCTFC-2507-J2316Medutest2025-Q398.914.2790.2Buyer-sourced2FAIL
AX-2025-019601TB-500TFCTFC-2503-R1539Medutest2025-Q399.014.14—Buyer-sourced0PASS
AX-2025-019477BPC-157JEEPJEEP-2506-R8215Janoshik2025-Q399.213.22—Buyer-sourced0PASS
AX-2025-019213SemaglutideSinoPepSNP-2502-G4494Janoshik2025-Q398.292.35102.9Buyer-sourced0PASS
AX-2025-018753Melanotan IIQSCQSC-2503-D7103VendorInvestigate2025-Q399.936.47102.4Buyer-sourced0PASS
AX-2025-020373IpamorelinMKMMKM-2504-N4424VendorInvestigate2025-Q398.985.5890.4Buyer-sourced1FAIL
AX-2025-019301IpamorelinAMBAMB-2505-J6078Kestrel2025-Q399.934.6892.5Buyer-sourced0PASS
AX-2025-019029Humanin (HNG)ASYASY-{CAT}-2221VendorInvestigate2025-Q398.634.8692.3Buyer-sourced0PASS
AX-2025-020608BPC-157SSASSA-2505-J7334Janoshik2025-Q398.753.7397.9Buyer-sourced1MARGINAL
AX-2025-020541VilonSSASSA-2508-B6436Kestrel2025-Q399.156.2193.5Buyer-sourced0FAIL
AX-2025-019244CJC-1295 (no DAC)AMBAMB-2507-S5238Janoshik2025-Q399.886.2089.1Buyer-sourced1MARGINAL
AX-2025-018966BPC-157ASYASY-{CAT}-1276Janoshik2025-Q399.596.30—Buyer-sourced0PASS
AX-2025-018730SS-31 (Elamipretide)QSCQSC-2502-M6829VendorInvestigate2025-Q397.735.36101.7Buyer-sourced1FAIL
AX-2025-021151SemaxSIGSIG-2504-6873Kestrel2025-Q398.3710.29—Buyer-sourced1FAIL
AX-2025-020943SermorelinWXTWXT-2506-D3300PeptideMeter2025-Q399.075.87103.2Supplier-supplied0PASS
AX-2025-020882BPC-157WXTWXT-2506-M1881VendorInvestigate2025-Q399.063.29—Buyer-sourced0PASS
AX-2025-020629SemaglutideGL BiochemGLBI-2505-V7913Janoshik2025-Q398.004.44—Buyer-sourced1MARGINAL
AX-2025-020303MK-677 (Ibutamoren mesylate)GGPepsGGPE-2507-S2892VendorInvestigate2025-Q399.935.00101.5Buyer-sourced0FAIL
AX-2025-019585TirzepatideTFCTFC-2508-G1453Janoshik2025-Q399.324.31—Buyer-sourced0PASS
AX-2025-019421IGF-1 LR3HYBHYB-2507-Y7485VendorInvestigate2025-Q398.015.1294.0Laboratory-retained0PASS
AX-2025-019300IpamorelinAMBAMB-2505-J6078Janoshik2025-Q399.414.88103.8Buyer-sourced0PASS
AX-2025-018992TirzepatideASYASY-{CAT}-1938Kestrel2025-Q398.974.80—Buyer-sourced0PASS
AX-2025-020794BPC-157CPCCPC-2503-T9775Janoshik2025-Q399.404.4493.7Buyer-sourced0PASS
AX-2025-020660TirzepatideSGNSGN-2506-J8349Medutest2025-Q398.231.89101.9Supplier-supplied0PASS
AX-2025-020230TirzepatideGGPepsGGPE-2502-J1624Janoshik2025-Q398.156.1192.9Buyer-sourced0PASS
AX-2025-020228TirzepatideGGPepsGGPE-2502-J1624Janoshik2025-Q397.655.9991.7Buyer-sourced0PASS
AX-2025-020168CJC-1295 with DACERPERP-2506-E9178Janoshik2025-Q399.094.8498.8Buyer-sourced0PASS
AX-2025-019867BPC-157HJHJ-2503-M6159Medutest2025-Q399.934.6391.9Buyer-sourced1MARGINAL
AX-2025-019848SemaglutideHomopeptideHOMO-2506-M5731PeptideMeter2025-Q397.965.88—Buyer-sourced1MARGINAL
AX-2025-019736SemaglutideHomopeptideHOMO-2505-V3835Janoshik2025-Q398.316.1491.4Buyer-sourced0PASS
AX-2025-019600TB-500TFCTFC-2503-R1539VendorInvestigate2025-Q399.403.45—Buyer-sourced0PASS
AX-2025-019597IGF-1 LR3TFCTFC-2508-H1748Kestrel2025-Q398.285.60103.0Buyer-sourced0PASS
AX-2025-019417IGF-1 LR3HYBHYB-2507-Y7485Medutest2025-Q399.424.6396.0Buyer-sourced0PASS
AX-2025-018868BPC-157TFSTFS-{CAT}-8964Janoshik2025-Q399.474.3791.4Buyer-sourced0PASS
AX-2025-018496MOTS-cWWBWWB-2505-G2801Janoshik2025-Q399.352.88—Buyer-sourced0PASS
AX-2025-021188GHRP-6PPGPPG-2508-N7068Janoshik2025-Q399.403.94—Laboratory-retained0PASS